Madica Launches Year-Round $200k Pre-Seed Investment Program for African Founders

Transitioning an early healthtech prototype or clinical diagnostic solution into a commercially viable enterprise requires targeted capital and dedicated venture building. The Madica Pre Seed Investment African Startups initiative provides early-stage equity funding specifically designed to back mission-driven founders whom mainstream VC corridors in Lagos, Nairobi, Cairo, or Cape Town often overlook.

Madica Pre Seed Investment African Startups Call Overview

Madica: Structured Pre-Seed Investment and Venture Building

• Funding Body: Madica (a sector-agnostic, pre-seed investment initiative launched and supported by Flourish Ventures).

• Target Applicants: Early-stage African ventures led by local, full-time founders and diverse teams across the continent, with an intentional focus on underrepresented entrepreneurs (including women founders and those outside primary tech hubs).

• Investment Scope & Mandate: Healthtech, digital health, and medical device ventures are fully in scope alongside other technology-enabled sectors. The Madica Pre Seed Investment African Startups program operates as a focused 12-to-18-month venture building window rather than a fundraising runway, prioritizing founders who intend to focus on core operations rather than raising concurrent funding rounds during the program.

• Eligibility Criteria & Exclusions:

  • Must possess a functional Minimum Viable Product (MVP) with early user traction (ideally the first few paying customers).

  • Founders must not have previously raised significant institutional capital.

  • Excluded: Concepts at the pre-MVP ideation stage, non-African ventures, corporate spin-offs, or teams planning a simultaneous fundraising round while participating in the program.

• Investment Amount & Terms: Up to $200,000 USD in exchange for equity ownership (dilutive capital), coupled with 12 to 18 months of intensive 1-on-1 mentorship, executive coaching, peer immersion trips, and direct introductions to follow-on global investors.

• Deadline: Rolling / Open Year-Round (No fixed application closing date).

• How to Apply:

  • Apply online via the direct application portal at madica.vc/apply.

  • Application Tip: Submit your application when your traction metrics and revenue graphs are strongest. Having a few paying customers is a strict, literal threshold—letters of intent (LOIs) and unpaid clinical pilots will not substitute for actual revenue. Outline concrete 12-to-18-month operational and market milestones rather than general long-term Series A projections.

Strategic Research Insights and Madica Pre Seed Investment African Startups Impact

Unlike non-dilutive grant capital, securing equity investment involves exchanging company ownership for growth capital. Early-stage health entrepreneurs should evaluate their capital strategy carefully: non-dilutive grants (such as Grand Challenges or the DIV Fund) are ideal for early clinical validation or R&D milestones, whereas the Madica Pre Seed Investment African Startups equity investment is best suited when capital is explicitly needed to hire core operational teams, scale sales channels, and establish commercial market validation.

Frequently Asked Questions

Is the funding from the Madica Pre Seed Investment African Startups program a grant or equity?

The funding offered is dilutive equity investment (up to $200,000 USD in exchange for equity ownership) accompanied by multi-month structured company-building support.

Can a healthtech startup apply without paying customers or revenue?

Startups must have a functional Minimum Viable Product (MVP) and ideally their first paying customers. Ideas without a working MVP or commercial traction do not meet the baseline screening criteria.